Logo image of SPCB

SUPERCOM LTD (SPCB) Stock Fundamental Analysis

USA - NASDAQ:SPCB - IL0010830961 - Common Stock

11.46 USD
-0.29 (-2.47%)
Last: 10/3/2025, 5:20:02 PM
Fundamental Rating

4

SPCB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. While SPCB seems to be doing ok healthwise, there are quite some concerns on its profitability. SPCB is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SPCB was profitable.
SPCB had negative earnings in 4 of the past 5 years.
SPCB had a negative operating cash flow in each of the past 5 years.
SPCB Yearly Net Income VS EBIT VS OCF VS FCFSPCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.04%, SPCB is in line with its industry, outperforming 52.42% of the companies in the same industry.
Looking at the Return On Equity, with a value of 1.90%, SPCB is in line with its industry, outperforming 53.23% of the companies in the same industry.
Industry RankSector Rank
ROA 1.04%
ROE 1.9%
ROIC N/A
ROA(3y)-8.43%
ROA(5y)-13.77%
ROE(3y)-105.34%
ROE(5y)-141.36%
ROIC(3y)N/A
ROIC(5y)N/A
SPCB Yearly ROA, ROE, ROICSPCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

With a decent Profit Margin value of 2.39%, SPCB is doing good in the industry, outperforming 60.48% of the companies in the same industry.
SPCB has a better Gross Margin (48.43%) than 83.06% of its industry peers.
In the last couple of years the Gross Margin of SPCB has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 2.39%
GM 48.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5Y4.68%
SPCB Yearly Profit, Operating, Gross MarginsSPCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

4

2. Health

2.1 Basic Checks

SPCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SPCB has more shares outstanding
SPCB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SPCB has an improved debt to assets ratio.
SPCB Yearly Shares OutstandingSPCB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
SPCB Yearly Total Debt VS Total AssetsSPCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.12, we must say that SPCB is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SPCB (-0.12) is worse than 79.03% of its industry peers.
SPCB has a Debt/Equity ratio of 0.71. This is a neutral value indicating SPCB is somewhat dependend on debt financing.
The Debt to Equity ratio of SPCB (0.71) is worse than 82.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -0.12
ROIC/WACCN/A
WACC7.4%
SPCB Yearly LT Debt VS Equity VS FCFSPCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

SPCB has a Current Ratio of 9.69. This indicates that SPCB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 9.69, SPCB belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
SPCB has a Quick Ratio of 9.06. This indicates that SPCB is financially healthy and has no problem in meeting its short term obligations.
SPCB's Quick ratio of 9.06 is amongst the best of the industry. SPCB outperforms 95.97% of its industry peers.
Industry RankSector Rank
Current Ratio 9.69
Quick Ratio 9.06
SPCB Yearly Current Assets VS Current LiabilitesSPCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.19% over the past year.
The Revenue has been growing slightly by 4.01% in the past year.
SPCB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.90% yearly.
EPS 1Y (TTM)103.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.67%
Revenue 1Y (TTM)4.01%
Revenue growth 3Y31.09%
Revenue growth 5Y10.9%
Sales Q2Q%-5.37%

3.2 Future

The Earnings Per Share is expected to grow by 0.66% on average over the next years.
The Revenue is expected to grow by 12.66% on average over the next years. This is quite good.
EPS Next Y73.11%
EPS Next 2Y-6.39%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue Next Year-3.98%
Revenue Next 2Y11.43%
Revenue Next 3Y12.66%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SPCB Yearly Revenue VS EstimatesSPCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
SPCB Yearly EPS VS EstimatesSPCB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 100 150 200

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.84, SPCB is valued on the expensive side.
78.23% of the companies in the same industry are more expensive than SPCB, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SPCB to the average of the S&P500 Index (27.86), we can say SPCB is valued slightly cheaper.
A Price/Forward Earnings ratio of 18.42 indicates a rather expensive valuation of SPCB.
Based on the Price/Forward Earnings ratio, SPCB is valued a bit cheaper than the industry average as 76.61% of the companies are valued more expensively.
SPCB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.84
Fwd PE 18.42
SPCB Price Earnings VS Forward Price EarningsSPCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

60.48% of the companies in the same industry are more expensive than SPCB, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.18
SPCB Per share dataSPCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y-6.39%
EPS Next 3Y0.66%

0

5. Dividend

5.1 Amount

SPCB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SUPERCOM LTD

NASDAQ:SPCB (10/3/2025, 5:20:02 PM)

11.46

-0.29 (-2.47%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners5.77%
Inst Owner Change0%
Ins Owners4.78%
Ins Owner ChangeN/A
Market Cap46.99M
Analysts82.5
Price Target15.3 (33.51%)
Short Float %4.63%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)676.77%
Min EPS beat(2)-130.55%
Max EPS beat(2)1484.08%
EPS beat(4)2
Avg EPS beat(4)355.68%
Min EPS beat(4)-226.87%
Max EPS beat(4)1484.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.96%
Min Revenue beat(2)-4.3%
Max Revenue beat(2)-1.62%
Revenue beat(4)1
Avg Revenue beat(4)3.89%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)23.28%
Revenue beat(8)5
Avg Revenue beat(8)18.01%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)7.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-40.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.15%
Valuation
Industry RankSector Rank
PE 20.84
Fwd PE 18.42
P/S 1.7
P/FCF N/A
P/OCF N/A
P/B 1.35
P/tB 2.12
EV/EBITDA 21.18
EPS(TTM)0.55
EY4.8%
EPS(NY)0.62
Fwd EY5.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.74
BVpS8.48
TBVpS5.4
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.04%
ROE 1.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.39%
GM 48.43%
FCFM N/A
ROA(3y)-8.43%
ROA(5y)-13.77%
ROE(3y)-105.34%
ROE(5y)-141.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5Y4.68%
F-ScoreN/A
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 9.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.69
Quick Ratio 9.06
Altman-Z -0.12
F-ScoreN/A
WACC7.4%
ROIC/WACCN/A
Cap/Depr(3y)97.09%
Cap/Depr(5y)83.67%
Cap/Sales(3y)12.3%
Cap/Sales(5y)12.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.67%
EPS Next Y73.11%
EPS Next 2Y-6.39%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue 1Y (TTM)4.01%
Revenue growth 3Y31.09%
Revenue growth 5Y10.9%
Sales Q2Q%-5.37%
Revenue Next Year-3.98%
Revenue Next 2Y11.43%
Revenue Next 3Y12.66%
Revenue Next 5YN/A
EBIT growth 1Y76.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year729.88%
EBIT Next 3Y136.88%
EBIT Next 5YN/A
FCF growth 1Y19.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.33%
OCF growth 3YN/A
OCF growth 5YN/A